Inventor · disambiguated record
Michael Chorev
Also filed as: CHOREV MICHAEL
37 granted patents·8 pending applications·1,130 citations·filing 1987–2021
98Inventor score
Top patents by PatentIndex Score
45 records- 0199US5217999AStyryl compounds which inhibit EGF receptor protein tyrosine kinaseYISSUM RES DEV CO·Filed 1992·Granted Jun 8, 1993·302 cites·21 claims
- 0295US6462222B1Aminoindan derivativesYISSUM RES DEV CO·Filed 2001·Granted Oct 8, 2002·82 cites·8 claims
- 0390US6538025B2Aminoindan derivativesTEVA PHARMA·Filed 2001·Granted Mar 25, 2003·31 cites·28 claims
- 0490US6251938B1Phenylethylamine derivativesTEVA PHARMA·Filed 1999·Granted Jun 26, 2001·45 cites·28 claims
- 0588USRE39616EAminoindan derivativesTECHNION RES & DEV FOUNDATION·Filed 2005·Granted May 8, 2007·9 cites·58 claims
- 0688US6303650B1Aminoindan derivativesYISSUM RES DEV CO·Filed 1999·Granted Oct 16, 2001·58 cites·40 claims
- 0788US5747456AContinuous low-dose administration of parathyroid hormone or its agonistBETH ISRAEL HOSPITAL·Filed 1996·Granted May 5, 1998·74 cites·21 claims
- 0888US4771124AParathyroid hormone antagonists with simplified synthetic methodologyMERCK & CO INC·Filed 1987·Granted Sep 13, 1988·59 cites·3 claims
- 0987US11161910B2Glycated CD59 peptides, their preparation, and uses thereofHARVARD COLLEGE·Filed 2018·Granted Nov 2, 2021·2 cites·10 claims
- 1087US4948807APhenyl carbamatesPROTERRA AG·Filed 1989·Granted Aug 14, 1990·115 cites·4 claims
- 1186US4968669AParathyroid hormone antagonistsMERCK & CO INC·Filed 1989·Granted Nov 6, 1990·55 cites·7 claims
- 1285US9421211B2N,N′-diarylurea compounds and N,N′-diarylthiourea compounds as inhibitors of translation initiationAKTAS BERTAL HUSEYIN·Filed 2010·Granted Aug 23, 2016·7 cites·2 claims
- 1385US9068006B2Glycated CD59 peptides, their preparation, and uses thereofHALPERIN JOSE A·Filed 2011·Granted Jun 30, 2015·6 cites·3 claims
- 1483US9417248B2Surrogates of post-translationally modified proteins and uses thereofCHOREV MICHAEL·Filed 2012·Granted Aug 16, 2016·4 cites·15 claims
- 1580US11891448B2Glycated CD59 peptides, their preparation, and uses thereofHARVARD COLLEGE·Filed 2021·Granted Feb 6, 2024·0 cites·8 claims
- 1679US5001223AParathyroid hormone antagonists with enhanced metabolic propertiesMERCK & CO INC·Filed 1989·Granted Mar 19, 1991·36 cites·2 claims
- 1777US7799757B2Analogs of parathyroid hormone and PTH-related protein as bone anabolic agentsCHOREV MICHAEL·Filed 2003·Granted Sep 21, 2010·7 cites·10 claims
- 1877US5093233AAntagonists with position 13 modificationMERCK & CO INC·Filed 1990·Granted Mar 3, 1992·43 cites·4 claims
- 1976US8257931B2Regulation of protein synthesisWAGNER GERHARD·Filed 2006·Granted Sep 4, 2012·5 cites·40 claims
- 2074US5717062ACyclic analogs of PTH and PTHrPBETH ISRAEL HOSPITAL·Filed 1995·Granted Feb 10, 1998·36 cites·16 claims
- 2171US2009226477A1Pth2 receptor selective compoundsDONG ZHENG XIN·Filed 2009·Application pending·0 cites
- 2270US5461034AOsteogenic growth polypeptides identified from regenerating bone marrowYISSUM RES DEV CO·Filed 1993·Granted Oct 24, 1995·44 cites·19 claims
- 2366US5814610AOsteogenic growth oligopeptides and pharmaceutical compositions containing themYISSUM RES DEV CO·Filed 1994·Granted Sep 29, 1998·21 cites·20 claims
- 2461US5149779AHumoral hypercalcemic factor antagonistsMERCK & CO INC·Filed 1990·Granted Sep 22, 1992·24 cites·3 claims
- 2560US7189692B2Synthetic peptides and pseudopeptides having osteogenic activity and pharmaceutical compositions containing the sameYISSUM RES DEV CO·Filed 2002·Granted Mar 13, 2007·1 cites·8 claims
- 2657US10732186B2Methods and reagents for the assessment of gestational diabetesHARVARD COLLEGE·Filed 2014·Granted Aug 4, 2020·0 cites·4 claims
- 2756US10309973B2Surrogates of post-translationally modified proteins and uses thereofHARVARD COLLEGE·Filed 2016·Granted Jun 4, 2019·0 cites·8 claims
- 2855US5087562AHumoral hypercalcemic factor antagonists with modification at position 13 . . .MERCK & CO INC·Filed 1990·Granted Feb 11, 1992·18 cites·3 claims
- 2954US9932300B2N,N′-diarylurea compounds and N,N′-diarylthiourea compounds as inhibitors of translation initiationHARVARD COLLEGE·Filed 2016·Granted Apr 3, 2018·0 cites·1 claims
- 3054US6479460B1Synthetic peptides and pseudopeptides having osteogenic activity and pharmaceutical compositions containing the sameYISSUM RES DEV CO·Filed 1998·Granted Nov 12, 2002·16 cites·7 claims
- 3152US8969573B2Compounds for the inhibition of cellular proliferationCHOREV MICHAEL·Filed 2011·Granted Mar 3, 2015·0 cites·1 claims
- 3252US2015315286A1Glycated cd59 peptides, their preparation, and uses thereofHARVARD COLLEGE·Filed 2015·Application pending·0 cites
- 3351USRE38761EStyryl compounds which inhibit EGF receptor protein tyrosine kinaseYISSUM RES DEV CO·Filed 1994·Granted Jul 19, 2005·13 cites·32 claims
- 3451US2024076272A1Activators of Heme Regulated Inhibitor Kinase (HRI)BRIGHAM & WOMENS HOSPITAL INC·Filed 2020·Application pending·0 cites
- 3551US2016106711A13-3-Di-Substituted-Oxindoles as Inhibitors of Translation InitiationHARVARD COLLEGE·Filed 2013·Application pending·0 cites
- 3650US9952200B2Cell based quality control bioassays for nutriceutical and medicinal productsHARVARD COLLEGE·Filed 2013·Granted Apr 24, 2018·0 cites·19 claims
- 3750US2005004037A1Osteogenic growth oligopeptides as stimulants of hematopoiesisYISSUM RES DEV CO·Filed 2004·Application pending·0 cites
- 3849US5242680AThiol-reactive maleimido-based radiolabeling reagentsMERCK & CO INC·Filed 1991·Granted Sep 7, 1993·12 cites·15 claims
- 3946US2014322723A1Diabetes diagnosis through the detection of glycated proteins in urinePresident and Dellows of Harvard College·Filed 2012·Application pending·0 cites
- 4045US2014314670A1Clicked somatostatin conjugated analogs for biological applicationsCENTRE NAT RECH SCIENT·Filed 2012·Application pending·0 cites
- 4144US11866506B2Anti-CD59 antibodiesMELLITUS LLC·Filed 2018·Granted Jan 9, 2024·0 cites·16 claims
- 4244US2016318856A1Substituted Urea eIF2alpha Kinase ActivatorsBRIGHAM & WOMENS HOSPITAL INC·Filed 2014·Application pending·0 cites
- 4334US5087561AHumoral hypercalcemic factor antagonists modified at position 13 by biotinMERCK & CO INC·Filed 1990·Granted Feb 11, 1992·5 cites·3 claims
- 4432US7531621B1PTH2 receptor selective compoundsSOD CONSEILS RECH APPLIC·Filed 1999·Granted May 12, 2009·0 cites·3 claims
- 4526US7132394B2PTH-like peptidesABIOGEN PHARMA SPA·Filed 2005·Granted Nov 7, 2006·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Michael Chorev files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →